Welcome to our dedicated page for LOEWS SEC filings (Ticker: L), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on LOEWS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into LOEWS's regulatory disclosures and financial reporting.
Loews Corporation director reports stock transactions under a pre-set plan. A reporting person serving as a director of Loews Corp (ticker L) filed a Form 4 detailing activity on December 1, 2025. The director exercised a stock appreciation right covering 2,250 shares of common stock at an exercise price of $38.67 per share and acquired the underlying shares. On the same date, the director reported dispositions of 806 shares at $108.13 per share and a sale of 1,444 shares at $108.10 per share. Following these transactions, the director beneficially owned 6,686 shares of Loews common stock directly. The filing notes that these trades were made pursuant to a Rule 10b5-1 trading plan adopted on August 7, 2024.
A shareholder of the issuer’s common stock, par value $0.01 per share, filed a Form 144 notice indicating a planned sale of up to 200,000 shares through broker Watermill Institutional Trading, LLC on the NYSE, with an indicated aggregate market value of $21,574,000. The notice states that 206,659,567 shares of this class were outstanding at the time referenced. The securities to be sold were contributed to a trust in three transactions dated December 19, 2023 (100,000 shares), May 23, 2024 (50,000 shares), and December 6, 2024 (50,000 shares), each shown as trust contributions with payment made on the respective acquisition dates.
Form 144 for insider sale of common stock of symbol L reports a planned sale of 1,442 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The shares have an aggregate market value of 155,642.14, with 206,659,567 common shares outstanding. The approximate sale date disclosed is 12/01/2025.
The filer acquired the 1,442 common shares on 12/01/2025 via a stock appreciation right (SAR) from the issuer as compensation. The notice also lists a prior sale by the same seller of 1,422 common shares on 09/02/2025, generating gross proceeds of 137,588.17. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
An affiliate of the issuer has filed a Form 144 notice to sell 1,442 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $155,916.25. These shares were acquired on 12/01/2025 from the issuer via a stock appreciation right (SAR) transaction as compensation, with payment also dated 12/01/2025.
The notice also reports that the same seller, Paul Fribourg, previously sold 1,422 common shares on 09/02/2025 for gross proceeds of $137,490.76. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations, as required under Rule 144.
Form 144 reports that a shareholder plans to sell 1,442 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 155,563.10. The issuer has 206,659,567 shares outstanding. The shares to be sold were acquired on 12/01/2025 from the issuer via a stock appreciation right (SAR) as compensation, with payment also dated 12/01/2025.
The person for whose account the securities are to be sold represents that they are not aware of any material adverse information about the issuer that has not been publicly disclosed. During the past three months, Walter Harris sold 1,421 common shares on 09/02/2025 for gross proceeds of 137,389.39.
Company L has a shareholder filing a notice under Rule 144 to sell 1,444 shares of common stock through Fidelity Brokerage Services on the NYSE. The planned sale has an aggregate market value of 156,093.66, compared with 206,659,567 shares of common stock outstanding. The shares to be sold were acquired on 12/01/2025 via a stock appreciation right (SAR) compensation transaction from the issuer, with payment also dated 12/01/2025.
Over the prior three months, the same seller, Ann E. Berman, sold 1,422 common shares on 09/02/2025 for gross proceeds of 137,466.45. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s operations and acknowledges that intentional misstatements or omissions constitute a federal criminal violation.
Loews Corp filed a Form 13F as a 13F Combination Report, indicating some positions are reported by other managers. The filing lists 24 reportable holdings with an aggregate 13F value of $12,036,062,772.
Loews noted it owned approximately 92% of the voting securities of CNA Financial Corporation as of 9/30/2025, and CNA is reporting on Loews’ behalf for certain CNA-related securities. The filing shows zero other included managers and identifies CNA Financial Corporation as an additional manager reporting.
Loews Corporation reported stronger Q3 results. Revenue rose to $4.67 billion from $4.47 billion, and net income attributable to Loews increased to $504 million from $401 million. Diluted EPS was $2.43 versus $1.82 a year ago, as insurance premiums grew and catastrophe losses declined.
For the first nine months, revenue reached $13.72 billion and net income attributable to Loews was $1.27 billion. Operating cash flow was solid at $2.66 billion (up from $2.08 billion), supporting buybacks of $690 million year‑to‑date and reducing average diluted shares to 209.88 million from 221.43 million. Shareholders’ equity rose to $19.22 billion, helped by a smaller accumulated other comprehensive loss of $1.16 billion versus $1.87 billion at year‑end.
At CNA, catastrophe losses were $41 million in Q3 (vs. $143 million) and $200 million year‑to‑date (vs. $313 million). The company recorded $190 million of unfavorable net prior year reserve development year‑to‑date, primarily in other professional liability and management liability. Investments remained sizeable with fixed maturities at $44.12 billion fair value, and Loews ended Q3 with $567 million in cash. As of October 31, 2025, common shares outstanding were 206,659,567.
Loews Corporation will expand its Board of Directors from 11 to 12 and elect Dino E. Robusto as a director, effective January 1, 2026.
Robusto served as CEO and Chairman of Loews subsidiary CNA Financial Corporation from 2016 to 2024 and has been CNA’s Executive Chairman since January 1, 2025. His term as Executive Chairman ends December 31, 2025, at which time he will leave the CNA Board of Directors. For 2025 at CNA, his compensation is an annual salary of $6 million, plus a bonus of up to $2 million, determined by CNA’s Compensation Committee.
Loews Corporation furnished an 8-K announcing that it issued a press release and posted earnings remarks covering its results of operations for the third quarter of 2025. The materials are provided under Item 2.02 and are included as Exhibit 99.1 (press release) and Exhibit 99.2 (earnings remarks).
The company states these materials are being furnished and shall not be deemed “filed” under the Exchange Act and will not be incorporated by reference into Securities Act documents. The press release and remarks were made available on November 3, 2025.